Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Tonix Pharmaceuticals Holding (TNXP) Equity Ratio (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 3 years of Equity Ratio data on record, last reported at 0.92 in Q3 2025.

  • For Q3 2025, Equity Ratio rose 17.2% year-over-year to 0.92; the TTM value through Sep 2025 reached 0.92, up 17.2%, while the annual FY2024 figure was 0.86, 25.4% up from the prior year.
  • Equity Ratio reached 0.92 in Q3 2025 per TNXP's latest filing, up from 0.9 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.94 in Q1 2025 and bottomed at 0.6 in Q2 2024.
  • Average Equity Ratio over 3 years is 0.83, with a median of 0.87 recorded in 2023.
  • Peak YoY movement for Equity Ratio: crashed 31.9% in 2024, then skyrocketed 49.73% in 2025.
  • A 3-year view of Equity Ratio shows it stood at 0.68 in 2023, then increased by 25.4% to 0.86 in 2024, then rose by 6.87% to 0.92 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.92 in Q3 2025, 0.9 in Q2 2025, and 0.94 in Q1 2025.